Universe Pharmaceuticals (UPC) Interest Expenses (2021 - 2025)

Universe Pharmaceuticals (UPC) has 4 years of Interest Expenses data on file, last reported at $2.2 billion in Q3 2025.

• For the quarter ending Q3 2025, Interest Expenses fell 1.42% year-over-year to $2.2 billion; the trailing twelve-month figure through Sep 2025 stood at $2.2 billion (down 1.42% YoY), and the FY2025 full-year result was $2.2 billion, down 1.42% from the prior year.
• Interest Expenses eased to $2.2 billion in Q3 2025, from $2.2 billion in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $2.2 billion in Q3 2024 to a low of $4929.0 in Q3 2021.
• A 4-year average of $1.5 billion and a median of $1.8 billion in 2023 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses surged 45.07% in 2024 and slipped 1.42% in 2025, its largest moves.
• Tracing UPC's Interest Expenses over 4 years: stood at $4929.0 in 2021, then jumped by 30746664.05% to $1.5 billion in 2023, then surged by 45.07% to $2.2 billion in 2024, then fell by 1.42% to $2.2 billion in 2025.
• Business Quant data shows UPC's Interest Expenses at $2.2 billion in Q3 2025, $2.2 billion in Q3 2024, and $1.5 billion in Q3 2023.